905722070

Bio-Rad Laboratories, Inc.

Could not find a ticker for this position, may be a filing error

A maker of instruments, reagents, and consumables for life-science research and clinical diagnostics, Bio-Rad's products help labs separate and analyze biological materials and run diagnostic tests. Founded in 1952 by UC Berkeley graduates David and Alice Schwartz, the company began in a Quonset hut in Berkeley, California. Its name is a portmanteau of its first product lines: biochemicals and radiochemicals.

CUSIP: 905722070HealthcareUS1 holder

Ownership Activity Financials Filings

Schedule 13D / 13G filings

The Vanguard Group

13G/APassive

% of class0%

Shares0

FiledMar 26, 2026

Norman D. Schwartz

13D/AActivist

% of class14.6%

Shares3.23M

FiledOct 30, 2025

Item 4 to the Schedule 13D is hereby amended, in pertinent part, as follows: The purpose of the Shareholders' ownership of Bio-Rad shares has been control of the Company. Norman D. Schwartz, along with other members of his family, control the management of the Company and may be deemed to be a "parent" of the Company as that term is defined in the Rules and Regulations of the Commission.

Alice N. Schwartz Revocable Trust

13D/AActivist

% of class8.1%

Shares1.78M

FiledOct 30, 2025

BlackRock, Inc.

13G/APassive

% of class7.4%

Shares1.62M

FiledOct 17, 2025

First Eagle Investment Management, LLC

13G/APassive

% of class11.4%

Shares2.53M

FiledAug 6, 2025

FIRST EAGLE GLOBAL FUND

13G/APassive

% of class8.5%

Shares1.88M

FiledAug 6, 2025

Alice N. Schwartz

13D/AActivist

% of class12.3%

Shares2.73M

FiledJul 18, 2025

Item 4 to the Schedule 13D is hereby amended, in pertinent part, as follows: The purposes of the transactions on December 10, 2018, December 3, 2019, December 7, 2020, November 9, 2021, November 7, 2022, December 5, 2023 and August 26, 2024 for Alice N. Schwartz and for the Alice N. Schwartz Revocable Trust set forth in Item 5 were estate planning. The purpose of the Shareholders' ownership of Bio-Rad shares has been control of the Company. Mrs. Schwartz, along with other members of her family, control the management of the Company and may be deemed to be a "parent" of the Company as that term is defined in the Rules and Regulations of the Commission.

Alice N. Schwartz Revocable Trust

13D/AActivist

% of class8%

Shares1.78M

FiledJul 18, 2025

Holder	Schedule	% of class	Shares	Filed
The Vanguard Group	13G/APassive	0%	0	Mar 26, 2026
Norman D. Schwartz	13D/AActivist	14.6%	3.23M	Oct 30, 2025
Item 4 to the Schedule 13D is hereby amended, in pertinent part, as follows: The purpose of the Shareholders' ownership of Bio-Rad shares has been control of the Company. Norman D. Schwartz, along with other members of his family, control the management of the Company and may be deemed to be a "parent" of the Company as that term is defined in the Rules and Regulations of the Commission.
Alice N. Schwartz Revocable Trust	13D/AActivist	8.1%	1.78M	Oct 30, 2025
Item 4 to the Schedule 13D is hereby amended, in pertinent part, as follows: The purpose of the Shareholders' ownership of Bio-Rad shares has been control of the Company. Norman D. Schwartz, along with other members of his family, control the management of the Company and may be deemed to be a "parent" of the Company as that term is defined in the Rules and Regulations of the Commission.
BlackRock, Inc.	13G/APassive	7.4%	1.62M	Oct 17, 2025
First Eagle Investment Management, LLC	13G/APassive	11.4%	2.53M	Aug 6, 2025
FIRST EAGLE GLOBAL FUND	13G/APassive	8.5%	1.88M	Aug 6, 2025
Alice N. Schwartz	13D/AActivist	12.3%	2.73M	Jul 18, 2025
Item 4 to the Schedule 13D is hereby amended, in pertinent part, as follows: The purposes of the transactions on December 10, 2018, December 3, 2019, December 7, 2020, November 9, 2021, November 7, 2022, December 5, 2023 and August 26, 2024 for Alice N. Schwartz and for the Alice N. Schwartz Revocable Trust set forth in Item 5 were estate planning. The purpose of the Shareholders' ownership of Bio-Rad shares has been control of the Company. Mrs. Schwartz, along with other members of her family, control the management of the Company and may be deemed to be a "parent" of the Company as that term is defined in the Rules and Regulations of the Commission.
Alice N. Schwartz Revocable Trust	13D/AActivist	8%	1.78M	Jul 18, 2025
Item 4 to the Schedule 13D is hereby amended, in pertinent part, as follows: The purposes of the transactions on December 10, 2018, December 3, 2019, December 7, 2020, November 9, 2021, November 7, 2022, December 5, 2023 and August 26, 2024 for Alice N. Schwartz and for the Alice N. Schwartz Revocable Trust set forth in Item 5 were estate planning. The purpose of the Shareholders' ownership of Bio-Rad shares has been control of the Company. Mrs. Schwartz, along with other members of her family, control the management of the Company and may be deemed to be a "parent" of the Company as that term is defined in the Rules and Regulations of the Commission.